Dissecting folliculitis of the scalp with marginal keratitis.
We describe a young man with dissecting folliculitis of the scalp, who subsequently developed marginal keratitis. We are unaware of any previous reports of this association. The aetiology of dissecting folliculitis is thought to relate to abnormal follicular occlusion with subsequent suppuration, although an infective process has never been established. Marginal keratitis is postulated, but not proven, to be caused by an enhanced immune response to Staphylococcus aureus antigens. We suggest that a similar abnormal response to infection may be important in these two conditions. This case also highlights ocular complications which may occur in patients with dissecting folliculitis.
Sivakumaran
S
S
Department of Dermatology, Addenbrooke's NHS Trust, Cambridge, UK.
Meyer
P
P
Burrows
N P
NP
D000287:Administration, Topical; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D004318:Doxycycline / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005499:Folliculitis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D005938:Glucocorticoids; D006801:Humans; D007634:Keratitis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D015242:Ofloxacin / Q000627:therapeutic use; D012536:Scalp Dermatoses / Q000150:complications* / Q000188:drug therapy / Q000473:pathology
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D003907:Dexamethasone; D015242:Ofloxacin; D004318:Doxycycline